NCT04781140

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2024-03-19Est. Completion: 2028-01

Enrollment target: 286 participants

Locations

The Center for Clinical Trials, Inc., Saraland, Alabama, United States
Preferred Research Partners, Inc., Little Rock, Arkansas, United States
Advanced Research Center (ARC), Inc., Anaheim, California, United States
Sun Valley Research Center, Imperial, California, United States
Alliance Research, Long Beach, California, United States
IMMUNOe Research Centers, Centennial, Colorado, United States
Luna Research Center, Coral Gables, Florida, United States
Sarkis Clinical Trials, Gainesville, Florida, United States
Clinical Neuroscience Solutions, Inc., Jacksonville, Florida, United States
Avantis Clinical Research LLC, Miami, Florida, United States
Hope Research Network, LLC., Miami, Florida, United States
Medical Research Group of Central Florida, Orange City, Florida, United States
Clinical Neuroscience Solutions, Inc., Orlando, Florida, United States
APG Research LLC, Orlando, Florida, United States
D&H Tamarac Research Center, Tamarac, Florida, United States
Pediatric Neurology and Epilepsy Specialists, Winter Park, Florida, United States

Disruptive Behavior DisordersConduct DisorderOppositional Defiant DisorderAttention-deficit/Hyperactivity Disorder

Background: Pediatric disruptive behavior disorders (DBDs) are characterized by severe irritability, anger, and temper …

Bethesda, United StatesEst. completion Dec 31, 2036

IrritabilityDisruptive Mood Dysregulation DisorderOppositional Defiant DisorderAttention Deficit Hyperactivity Disorder

Background: Irritability is defined as proneness to anger that may impair a person's ability to function. It is a commo…

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.